11
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T27979 |
Masilukast
ICI-D-3523,ZD-3523,ICI D-3523,MCC-847,SA-09012,D-3523 |
Leukotriene Receptor | GPCR/G Protein |
Masilukast(MCC-847) 是一种口服的白三烯D4 (LTD4) 受体拮抗剂,可用于研究与炎症相关的疾病。 | |||
T26519 |
Ablukast
Ro 23-3544,阿鲁司特 |
Leukotriene Receptor | GPCR/G Protein |
Ablukast (Ro 23-3544) 是白三烯受体的选择性拮抗剂,也是LTD4受体拮抗剂。可改善 LTC4 和抗原诱导的支气管狭窄。 | |||
T10501 |
YM158 free base
YM-57158 |
Others | Others |
YM158 free base is a potent and selective antagonist of TXA2 and LTD4 receptor (pA2s: about 8.81 and 8.87). | |||
T10873 |
CP-96486
|
Others | Others |
CP-96486 is a potent and orally active antagonist of leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor (Kis: 20 and 24 nM). | |||
T27877 |
LY 163443
LY163443,LY-163443 |
||
LY 163443 is an dual receptor antagonist of LTD4 and LTE4. | |||
T27912 |
LY 290324
LY-290324,LY290324 |
||
LY 290324 is an orally active, potent and selective antagonist of cysteinyl leukotriene (LTD4) receptor. | |||
T10872 |
CP-96021 hydrochloride
|
Others | Others |
CP-96021 hydrochloride is a potent and orally active antagonist of leukotriene D4 (LTD4)/platelet activating factor receptor (Kis: 34 nM and 37 nM). | |||
T15647 |
Tipelukast
MN 001,KCA 757 |
Leukotriene Receptor | GPCR/G Protein |
Tipelukast (KCA 757) 是一种新型可口服的白三烯受体 (leukotriene receptor) 拮抗剂,是具有抗炎活性,可减少纤维化,下调 TIMP-1、1 型胶原蛋白。Tipelukast 可用于研究哮喘疾病。 | |||
T19674 |
Verlukast
MK 0679,MK-679,L 668,019,MK 679,L 668019,L-668,019 |
||
Verlukast is an (R)-enantiomer of MK-571 and a potent and selective LTD4 receptor antagonist. Verlukast showed [3H]leukotriene D4 binding in guinea-pig (IC50 = 3.1 +/- 0.5 nM) and human (IC50 = 8.0 +/- 3.0 nM) lung homogenates and dimethyl sulfoxide diffe | |||
T37652 |
5(S),6(R)-DiHETE
|
||
5(S),6(R)-DiHETE is a dihydroxy polyunsaturated fatty acid and a nonenzymatic hydrolysis product of leukotriene A4 (LTA4). Mouse liver cytosolic epoxide hydrolase catalyzes the conversion of LTA4 to 5(S),6(R)-DiHETE. It is a weak LTD4 receptor agonist in guinea pig lung membranes. It induces guinea pig ileum contraction with an ED50 value of 1.3 μM. | |||
T37980 |
N-methyl Leukotriene C4
N-methyl Leukotriene C4 |
||
Produced by neutrophils, macrophages, mast cells, and by transcellular metabolism in platelets, leukotriene C4 (LTC4) is the parent cysteinyl leukotriene formed by the LTC4 synthase-catalyzed conjugation of glutathione to LTA4. It is one of the constituents of slow-reacting substance of anaphylaxis (SRS-A) and exhibits potent smooth muscle contracting activity. LTC4, however, is rapidly metabolized to LTD4 and LTE4, which makes the characterization of LTC4 pharmacology difficult. N-methyl Leukot... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03749 |
CYSLTR1 Protein, Human, Recombinant (His)
Cysteinyl leukotriene receptor 1,G-protein coupled ... |
Human | E. coli |
Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4. |